Paranasal Sinus Squamous Cell Carcinoma
NCI Definition: A squamous cell carcinoma that arises from the mucosal epithelial surface of the ethmoid, frontal, maxillary, or sphenoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. 
There are 2 clinical trials for paranasal sinus squamous cell carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain paranasal sinus squamous cell carcinoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 1/phase 2 (1 open).
Berzosertib, cetuximab, and cisplatin are the most common interventions in paranasal sinus squamous cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.